8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001415889-16-006525
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading cdxc8k_july142016.htm…